Scher’s Conflict of Interest
Just wanted to make sure everyone has seen the conflict of interest (COI) from one of Provenge’s most outspoken critics.
I have seen this before, but Andrew Horowitz recent comment in his seekingalpha article made me want to repost it here.
To Scher… This really does look as bad as it seems. Everyone is entitled to their vote on the panel, so I will not refute that. But your constant criticism out side the FDA, with this COI in hand makes you a piece of #&$* in my eyes.
